Anjan Drug (Sekhmet)
India
Hybrid — also manufactures internal programs
Program data pending ClinicalTrials.gov matching
Profiled
Not yet scored
✓ FDA Inspections (1)
○ Clinical Trials
○ SEC Filings
○ Press
○ EMA GMP
○ MHRA GMP
✓ HC GMP (5)
Quick Facts: Anjan Drug (Sekhmet)
- Signal Score
- Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works
- Headquarters
- India
- Website
- https://sekhmetpharma.com/
- Modalities
- Small Molecule API
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
About Anjan Drug (Sekhmet)
Anjan Drug (Sekhmet) makes its own pharmaceutical products and also offers contract development and manufacturing services. Capabilities: Small Molecule API. 2 manufacturing sites registered with the U.S. FDA and Health Canada. Website: https://sekhmetpharma.com/
Signal Score
Profiled, not yet scored.
Scores are published after regulatory evidence is attached and reviewed.
How scoring works
Anjan Drug (Sekhmet) FDA Inspection History
2025-07
NAI
VAI
OAI
| Date | Site | Type | Observations | Classification |
|---|---|---|---|---|
| 2025-07-11 |
Anjan Drug Private Limited
Alathur
Company-level
|
Drug Quality Assurance | No | No Action Indicated (NAI) |
Source: FDA Data Dashboard · Retrieved Oct 31, 2026
Hiring Activity Beta
Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source:
public careers pages
· Checked Oct 30, 2026
Frequently Asked Questions About Anjan Drug (Sekhmet)
How many FDA inspections does Anjan Drug (Sekhmet) have on record?
CDMO Signal tracks 1 FDA inspection for Anjan Drug (Sekhmet), sourced from the FDA inspection database. See the full inspection history above.
Has Anjan Drug (Sekhmet) received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for Anjan Drug (Sekhmet).
Does Anjan Drug (Sekhmet) have a CDMO Signal Score?
Not yet. Anjan Drug (Sekhmet) is profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed.
Evaluating Anjan Drug (Sekhmet) for a manufacturing program?
Use the free AI matchmaker to compare Anjan Drug (Sekhmet) against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
Similar CDMOs
Sai Life Sciences
India
Small Molecule API
Coral Drugs
India
Small Molecule API
Aarti Pharmalabs
India
Small Molecule API
Anthem Biosciences
India
Small Molecule API, Peptides & Oligos, Biologics
Divi's Laboratories
Hyderabad, Telangana, India
Small Molecule API, Intermediates, Custom Synthesis, Peptides
Compare Anjan Drug (Sekhmet) with another CDMO
Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.